(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MUCINEX DM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MUCINEX DM

ST13

US500000088108705

Class

5

Filing

88108705

Registration

5744739

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

11/05/2024

Trademark type

Combined

Nice classes

5

Filing date

09/07/2018

Registration date

05/07/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/05/2024

Last transaction

11/05/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

01/31/2016

First use in commerce

01/31/2016

Drawing code

3

Owner type

16

Owner location

PARSIPPANY, NJ

Examiner

COGAN, BRITTNEY

Current location

Historical data usage

Mark description

The mark consists of the stylized word "MUCINEX" in blue followed by the stylized letters "DM" in green with a grey outline on a white background below which is blue filed, all of which are surrounded by a grey outline.

Holders and representatives

Holders

RB HEALTH (US) LLC
RB HEALTH (US) LLC

Representatives

Mark Lerner, Esq. DUANE MORRIS LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparationspharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds ; allergy relief medication

Publications

History of USPTO decisions and trademark events.

20 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/05/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/05/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/05/2024

E815

TEAS SECTION 8 & 15 RECEIVED

05/16/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/07/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/07/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/19/2019

PUBO

PUBLISHED FOR OPPOSITION

02/19/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/30/2019

ALIE

ASSIGNED TO LIE

01/14/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/18/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

12/18/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/18/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

12/18/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/18/2018

DOCK

ASSIGNED TO EXAMINER

12/18/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/21/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/18/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/15/2018

NWAP

NEW APPLICATION ENTERED

09/11/2018

Continuous trademark protection

Get notified about every new filing that threatens MUCINEX DM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.